187 related articles for article (PubMed ID: 11930825)
1. Drug susceptibility testing of Malassezia furfur strains to antifungal agents.
Zissova LG; Kantarjiev TB; Kuzmanov AH
Folia Med (Plovdiv); 2001; 43(3):10-2. PubMed ID: 11930825
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activities of azole agents against the Malassezia species.
Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activity of ketoconazole and other azoles against Malassezia furfur in vitro and in vivo.
Strippoli V; Piacentini A; D'Auria FD; Simonetti N
Infection; 1997; 25(5):303-6. PubMed ID: 9334866
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates].
Sancak B; Ayhan M; Karaduman A; Arikan S
Mikrobiyol Bul; 2005 Jul; 39(3):301-8. PubMed ID: 16358489
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology,
Li W; Zhang ZW; Luo Y; Liang N; Pi XX; Fan YM
J Med Microbiol; 2020 Mar; 69(3):436-442. PubMed ID: 32068525
[No Abstract] [Full Text] [Related]
6. Ketoconazole inhibits Malassezia furfur morphogenesis in vitro under filamentation optimized conditions.
Youngchim S; Nosanchuk JD; Chongkae S; Vanittanokom N
Arch Dermatol Res; 2017 Jan; 309(1):47-53. PubMed ID: 27885419
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of modified Leeming-Notman media in a resazurin microtiter assay in the evaluation of in-vitro activity of fluconazole against Malassezia furfur ATCC 14521.
Far FE; Al-Obaidi MMJ; Desa MNM
J Mycol Med; 2018 Sep; 28(3):486-491. PubMed ID: 29753721
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility testing of Malassezia furfur against rilopirox.
Nenoff P; Haustein UF
Skin Pharmacol; 1997; 10(5-6):275-80. PubMed ID: 9449166
[TBL] [Abstract][Full Text] [Related]
9. [In vitro antifungal activity of azoles and amphotericin B against Malassezia furfur by the CLSI M27-A3 microdilution and Etest
Galvis-Marín JC; Rodríguez-Bocanegra MX; Pulido-Villamarín ADP; Castañeda-Salazar R; Celis-Ramírez AM; Linares-Linares MY
Rev Iberoam Micol; 2017; 34(2):89-93. PubMed ID: 28214276
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine.
Gupta AK; Kohli Y; Li A; Faergemann J; Summerbell RC
Br J Dermatol; 2000 Apr; 142(4):758-65. PubMed ID: 10792228
[TBL] [Abstract][Full Text] [Related]
11. Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
Brilhante RSN; Rocha MGD; Guedes GMM; Oliveira JS; Araújo GDS; España JDA; Sales JA; Aguiar L; Paiva MAN; Cordeiro RA; Pereira-Neto WA; Pinheiro AQ; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
Vet Microbiol; 2018 Jul; 220():47-52. PubMed ID: 29885800
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Garau M; Pereiro M; del Palacio A
Antimicrob Agents Chemother; 2003 Jul; 47(7):2342-4. PubMed ID: 12821494
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.
Rojas FD; Córdoba SB; de Los Ángeles Sosa M; Zalazar LC; Fernández MS; Cattana ME; Alegre LR; Carrillo-Muñoz AJ; Giusiano GE
Mycoses; 2017 Feb; 60(2):104-111. PubMed ID: 27625339
[TBL] [Abstract][Full Text] [Related]
14. The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole.
Van Gerven F; Odds FC
Mycoses; 1995; 38(9-10):389-93. PubMed ID: 8569815
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
[TBL] [Abstract][Full Text] [Related]
16. In vitro sensitivity of Malassezia furfur isolates from HIV-positive and negative patients to antifungal agents.
Ehemann K; Contreras A; Celis-Ramírez AM
Biomedica; 2023 Aug; 43(Sp. 1):120-131. PubMed ID: 37721914
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial and anti-inflammatory effects of Cecropin A(1-8)-Magainin2(1-12) hybrid peptide analog p5 against Malassezia furfur infection in human keratinocytes.
Ryu S; Choi SY; Acharya S; Chun YJ; Gurley C; Park Y; Armstrong CA; Song PI; Kim BJ
J Invest Dermatol; 2011 Aug; 131(8):1677-83. PubMed ID: 21593770
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Jesus FP; Lautert C; Zanette RA; Mahl DL; Azevedo MI; Machado ML; Dutra V; Botton SA; Alves SH; Santurio JM
Vet Microbiol; 2011 Aug; 152(1-2):161-4. PubMed ID: 21658868
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of R126638 and ketoconazole against Malassezia species.
Faergemann J; Ausma J; Borgers M
Acta Derm Venereol; 2006; 86(4):312-5. PubMed ID: 16874415
[TBL] [Abstract][Full Text] [Related]
20. Malassezia species: the need to establish epidemiological cutoff values.
Rojas FD; Sosa MLÁ; Latorre W; Mussin J; Alegre L; Giusiano G
Med Mycol; 2022 Aug; 60(8):. PubMed ID: 35772016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
